Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Serum MIS values have been reported to be elevated in patients with ovarian tumors such as granulosa cell tumors (GCT), sex cord tumors with annular tubules (SCTAT), and Sertoli-Leydig cell tumors. We hypothesized that MIS determination would aid in the diagnosis and treatment of girls with ovarian tumors. Therefore, we measured MIS concentrations in 19 girls with these types of tumors. Clinical information on presentation was available for 10 girls, and included abdominal mass or pain in three girls and precocious puberty in 7 of 8 prepubertal girls (88%). All patients were treated with surgical removal of the tumor. Nine of twelve (75%) patients had an elevated pre-operative MIS value (see table). Post-operative serum MIS concentration was measured in 16 patients and was normal in all.
In conclusion, we found that a high percentage of girls with granulosa cell tumors, sex cord tumors with annular tubules, and Sertoli-Leydig cell tumors had elevated serum MIS values. Therefore, measurement of serum MIS concentration may be helpful diagnostically in identifying ovarian tumors in girls with non-centrally mediated precocious puberty. Because MIS values fell to the normative range postoperatively in all of our patients, follow-up determination of MIS may be useful in evaluating the completeness of surgical excision of these tumors.
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
Lane, A., Lee, M., Donahoe, P. et al. Mullerian Inhibiting Substance (MIS) Levels in Children with Ovarian Tumors† 447.
Pediatr Res43
(Suppl 4), 79 (1998). https://doi.org/10.1203/00006450-199804001-00468